Pacira BioSciences, Inc. (PCRX) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q2 26	$0.65	$0.73	+12.3%	—	$192.4M	—
Q1 26	$0.56	$0.6	+7.1%	—	$177.4M	—
Q4 25	$0.9	$0.57	-36.7%	—	$196.9M	—
Q3 25	$0.65	$0.7	+7.7%	—	$179.5M	—
Q2 25	$0.71	$0.74	+4.2%	—	$181.1M	—
Q1 25	$0.6	$0.62	+3.3%	—	$168.9M	—
Q4 24	$0.83	$0.91	+9.6%	—	$187.3M	—
Q3 24	$0.7	$0.79	+12.9%	—	$168.6M	—
Q2 24	$0.7	$0.89	+27.1%	—	$178M	—
Q1 24	$0.62	$0.62	0.0%	—	$167.1M	—
Q4 23	$0.87	$0.89	+2.3%	—	$181.2M	—
Q3 23	$0.78	$0.72	-7.7%	—	$163.9M	—
Q2 23	$0.76	$0.78	+2.6%	—	$169.5M	—
Q1 23	$0.62	$0.53	-14.5%	—	$160.3M	—
Q4 22	$0.83	$0.8	-3.6%	—	$172M	—
Q3 22	$0.76	$0.64	-15.8%	—	$167.5M	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	$0.16	—	—	$726.4M	—
FY24	—	-$2.15	—	—	$701M	—
FY23	—	$0.91	—	—	$675M	—
FY22	—	$0.35	—	—	$666.8M

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$276.4M	$286.6M	$337.3M	$421M	$429.6M	$541.5M	$666.8M	$675M	$701M	$726.4M
YoY change	+11%	+3.71%	+17.7%	+24.8%	+2.05%	+26%	+23.1%	+1.22%	+3.85%	+3.63%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	276.4M	286.6M	337.3M	421M	429.6M	541.5M	666.8M	675M	701M	726.4M
Cost of revenue	110.1M	87.9M	86.8M	106.7M	117.3M	140.3M	199.3M	184.7M	170.4M	149.7M
Gross profit	166.3M	198.7M	250.4M	314.3M	312.3M	401.3M	467.5M	490.3M	530.5M	576.7M
Gross margin	60.2%	69.3%	74.3%	74.7%	72.7%	74.1%	70.1%	72.6%	75.7%	79.4%
Research & development	45.7M	57.3M	55.7M	72.1M	59.4M	55.5M	84.8M	76.3M	81.6M	117.3M
Selling, general & administrative	152.6M	161.5M	177.3M	200.8M	193.5M	199.3M	254.5M	269.4M	294.1M	368.8M
Operating expenses	198.3M	218.8M	233M	272.9M	252.9M	254.9M	339.3M	345.7M	375.7M	500.2M
Operating income	-32M	-20.1M	17.5M	35.7M	51.5M	132.8M	70.9M	87.3M	97.6M	19.2M
Operating margin	-11.6%	-7%	5.18%	8.48%	12%	24.5%	10.6%	12.9%	13.9%	2.64%
Non-operating income, net	-82K	-8.4M	-2.5M	-30.2M	-10.4M	-45.6M	-22.2M	-16.8M	-163.8M	-7.6M
Pretax income	-37.8M	-42.5M	-425K	-10.7M	20.1M	56.4M	13.3M	61.7M	-63.1M	16.9M
Income tax	105K	140K	46K	268K	-125.4M	14.4M	-2.6M	19.7M	36.5M	9.8M
Net income	-37.9M	-42.6M	-471K	-11M	145.5M	42M	15.9M	42M	-99.6M	7M
Net margin	-13.7%	-14.9%	-0.14%	-2.62%	33.9%	7.75%	2.39%	6.22%	-14.2%	0.97%
EBITDA	-18.5M	-3.4M	34.6M	56M	76.7M	156.9M	151.3M	171.2M	192.5M	123.5M
EPS	-1.02	-1.07	-0.01	-0.27	3.41	0.95	0.35	0.91	-2.15	0.16
Diluted EPS	-1.02	-1.07	-0.01	-0.27	3.33	0.92	0.34	0.89	-2.15	0.16

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	163.9M	181.2M	167.1M	178M	168.6M	187.3M	168.9M	181.1M	179.5M	196.9M	177.4M	192.4M
Cost of revenue	39.8M	47.7M	47.4M	44.3M	38.9M	39.9M	34.3M	40.9M	34.3M	40.3M	36.4M	44.2M
Gross profit	124.2M	133.6M	119.7M	133.8M	129.7M	147.4M	134.6M	140.2M	145.2M	156.6M	141M	148.2M
Gross margin	75.8%	73.7%	71.6%	75.1%	76.9%	78.7%	79.7%	77.4%	80.9%	79.5%	79.5%	77%
Research & development	20.8M	19.5M	18.2M	20.3M	19.1M	23.9M	25.3M	28.2M	26M	37.5M	28.1M	30.2M
Selling, general & administrative	67.9M	65.8M	72M	68.1M	74.3M	79.6M	86.8M	88.6M	91.8M	101.6M	93.9M	91.8M
Operating expenses	88.8M	85.3M	90.3M	88.5M	93.4M	103.5M	112.1M	116.8M	117.8M	139.1M	122M	122.1M
Operating income	21.1M	34M	15.1M	31M	21.9M	29.5M	8.2M	9.1M	13.2M	-10.9M	4.6M	11.9M
Operating margin	12.9%	18.7%	9.04%	17.4%	13%	15.8%	4.84%	5.04%	7.33%	-5.55%	2.61%	6.16%
Non-operating income, net	-3.8M	-283K	-2.1M	4.7M	-161.6M	-4.9M	-1.8M	-11.4M	-7.9M	13.1M	2.1M	-7.6M
Pretax income	16.6M	33.7M	13.6M	36.6M	-138.9M	25.5M	8.7M	-1.9M	9.5M	571K	5M	2.6M
Income tax	5.7M	8.8M	4.7M	17.7M	4.6M	9.5M	3.9M	2.9M	4.1M	-1.1M	2.1M	-2.1M
Net income	10.9M	24.9M	9M	18.9M	-143.5M	16M	4.8M	-4.8M	5.4M	1.6M	2.9M	4.7M
Net margin	6.62%	13.7%	5.37%	10.6%	-85.1%	8.57%	2.85%	-2.68%	3.03%	0.83%	1.64%	2.42%
EBITDA	41.2M	55.7M	36.6M	53.8M	46.7M	55.4M	39.8M	29.9M	42.1M	12M	27.2M	34.5M
EPS	0.23	—	0.19	0.41	-3.11	0.35	0.1	-0.11	0.12	0.04	0.07	0.12
Diluted EPS	0.23	—	0.19	0.39	-3.11	0.34	0.1	-0.11	0.12	0.04	0.07	0.12

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	1.2B	1.8B	1.8B	1.9B	2.6B	2.7B	1.8B	1.6B	871.3M	1.2B	999M
Enterprise value	1.1B	1.8B	1.7B	1.9B	2.6B	3.1B	2.2B	1.9B	1B	1.3B	1.2B
Shares outstanding	37.2M	39.8M	40.9M	41.5M	42.7M	44.3M	45.5M	46.2M	46.2M	44.6M	44.6M

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	—	—	—	—	17.5	63.4	110.5	37.2	—	164	72.4
P/S	4.35	6.34	5.22	4.47	5.94	4.92	2.64	2.31	1.24	1.59	1.34
P/B	5.49	6.5	5.48	5.3	4.12	3.65	2.27	1.79	1.12	1.66	1.5
EV/EBITDA	-61.6	-528.6	48.2	34.7	33.5	20	14.8	10.9	5.33	10.8	9.38
EV/Sales	4.12	6.22	4.94	4.61	5.99	5.79	3.35	2.77	1.46	1.84	1.56
Earnings yield	—	—	—	—	5.7%	1.58%	0.91%	2.69%	—	0.61%	1.38%
FCF yield	0.73%	-0.08%	1.95%	3.21%	1.54%	3%	6.55%	8.94%	20.5%	11.8%	9.84%
PEG	—	—	—	—	—	—	—	—	—	—	-0.35

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	60.2%	69.3%	74.3%	74.7%	72.7%	74.1%	70.1%	72.6%	75.7%	79.4%	77%
Operating margin	-11.6%	-7%	5.18%	8.48%	12%	24.5%	10.6%	12.9%	13.9%	2.64%	6.17%
Net margin	-13.7%	-14.9%	-0.14%	-2.62%	33.9%	7.75%	2.39%	6.22%	-14.2%	0.97%	1.96%
ROE	-17.3%	-15.2%	-0.15%	-3.1%	23.5%	5.75%	2.05%	4.82%	-12.8%	1.01%	2.05%
ROA	-9.69%	-6.78%	-0.07%	-1.33%	11.4%	2.02%	0.95%	2.66%	-6.41%	0.56%	1.48%
ROIC	-20.6%	-8.2%	7.64%	8.61%	8.06%	8.22%	5.68%	5.04%	10.5%	0.92%	1.86%
Return on tangible assets	-12.7%	-8.23%	-0.08%	-2.6%	16.5%	7.82%	5.81%	14.9%	-14.2%	1.44%	2.31%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	5.42	6.96	7.88	3.79	2.57	1.66	3.37	5.24	2.4	4.54	5.04
Quick ratio	4.72	6.22	7.08	3.25	2.32	1.47	2.72	4.17	2	3.28	3.94
Debt / equity	0.5	0.99	0.91	0.99	0.87	1.55	0.99	0.67	0.82	0.6	0.61
Debt / assets	0.28	0.44	0.42	0.42	0.42	0.54	0.45	0.37	0.41	0.33	0.33
Net debt / EBITDA	3.46	10.3	-2.67	1.07	0.25	3.01	3.14	1.8	0.8	1.46	1.39
Interest coverage	-4.87	-1.55	0.98	0.51	1.85	2.95	1.37	4.56	-3.7	2.16	2.33
Effective tax rate	0%	0%	0%	0%	0%	25.6%	0%	32%	0%	58.3%	17.1%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	7.42	7.2	8.24	10.1	10.1	12.2	14.6	14.6	15.2	16.3	17.9
EPS (basic)	-1.02	-1.07	-0.01	-0.27	3.41	0.95	0.35	0.91	-2.15	0.16	0.16
EPS (diluted)	-1.02	-1.07	-0.01	-0.27	3.33	0.92	0.34	0.89	-2.15	0.16	0.35
Book value per share	5.88	7.02	7.85	8.55	14.5	16.5	17	18.8	16.8	15.6	16.9
FCF per share	0.23	-0.04	0.84	1.45	0.92	1.8	2.53	3.02	3.87	3.07	4.45
Cash per share	4.64	7.82	9.37	7.03	12.2	14.8	6.34	6.03	10.5	5.35	6.3
Capex per share	0.66	0.48	0.35	0.24	0.89	1.04	0.66	0.33	0.23	—	—

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	8.94%	6.72%	4.3%	2.41%	8.8%	8.47%	4.51%	2.25%	1.52%	—	—
Capex / operating cash flow	72.8%	1.6K%	31%	25.2%	50.5%	38.5%	22.8%	8.95%	36.3%	—	—
Payout ratio	—	—	—	—	—	—	—	—	—	—	0%

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	$163.9M	$181.2M	$167.1M	$178M	$168.6M	$187.3M	$168.9M	$181.1M	$179.5M	$196.9M	$177.4M	$192.4M
YoY change	-2.11%	+5.4%	+4.23%	+5.05%	+2.83%	+3.32%	+1.08%	+1.73%	+6.49%	+5.14%	+5%	+6.24%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	172.6M	311.3M	383.5M	291.9M	521.7M	656.4M	288.7M	278.6M	484.6M	238.4M
Receivables	29.9M	31.7M	38M	47.5M	53M	96.3M	98.4M	105.6M	113.3M	124.1M
Inventory	31.3M	41.4M	48.6M	58.3M	64.7M	98.5M	96.1M	104.4M	125.3M	152.9M
Total current assets	243.1M	391.1M	478M	408.6M	651.6M	866M	498.3M	510M	745.1M	548M
Property, plant & equipment	101M	107M	108.7M	142.8M	211.2M	264.8M	254.4M	234.9M	216.4M	182.5M
Goodwill & intangibles	93.5M	110.4M	124.1M	407.9M	392.1M	1.5B	1.4B	1.3B	851.9M	776.6M
Total assets	391.5M	628.4M	689.4M	831.1M	1.3B	2.1B	1.7B	1.6B	1.6B	1.3B
Accounts payable	7.5M	14.7M	14.4M	12.8M	10.4M	10.5M	15.2M	15.7M	19.1M	15.2M
Short-term debt	—	324K	338K	4.9M	157.1M	382.6M	42.8M	17.4M	210.7M	9.8M
Total current liabilities	44.8M	56.2M	60.7M	107.7M	253.3M	521.1M	147.8M	97.4M	309.9M	120.6M
Long-term debt	108.7M	276.2M	290.6M	347M	384.1M	746.3M	720.6M	568.6M	428.2M	408.4M
Total liabilities	172.5M	348.9M	368.1M	476.1M	654.8M	1.3B	906.2M	704.3M	775.2M	571.8M
Shareholders' equity	219M	279.5M	321.2M	354.9M	619.7M	730.4M	775M	870.1M	778.3M	693.1M
Total debt	108.7M	276.5M	290.9M	351.9M	541.1M	1.1B	763.4M	586M	638.9M	418.2M
Net debt	72.8M	222.4M	158.4M	273.7M	441.2M	543.3M	659.3M	432.7M	362.1M	259.7M

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Cash & short-term investments	235.2M	278.6M	325.9M	404.2M	453.8M	484.6M	493.6M	445.9M	246.3M	238.4M	202.2M	251M
Receivables	97M	105.6M	101.6M	104.8M	100.7M	113.3M	104.7M	114.4M	115.3M	124.1M	125.6M	132.4M
Inventory	96.5M	104.4M	96.8M	103.4M	111.9M	125.3M	133.8M	148.2M	157.7M	152.9M	150.4M	134.6M
Total current assets	447.3M	510M	543.1M	632.2M	690M	745.1M	760M	745.6M	562.8M	548M	515M	615.2M
Property, plant & equipment	239.2M	234.9M	230.4M	225.1M	220.7M	216.4M	213.2M	201.7M	191.7M	182.5M	175.7M	175.2M
Goodwill & intangibles	1.3B	1.3B	1.3B	1.2B	880.6M	851.9M	913M	885.7M	805.4M	776.6M	746M	610.3M
Total assets	1.5B	1.6B	1.6B	1.6B	1.5B	1.6B	1.6B	1.5B	1.3B	1.3B	1.2B	1.2B
Accounts payable	16.5M	15.7M	9M	18.7M	19.4M	19.1M	23.2M	30.1M	17.7M	15.2M	14M	17.5M
Short-term debt	17.3M	17.4M	17.6M	9.1M	210.7M	210.7M	211.5M	212M	9.7M	9.8M	9.8M	10.3M
Total current liabilities	93.7M	97.4M	93.4M	92.7M	306.4M	309.9M	314.7M	313.2M	107.1M	120.6M	108.8M	122M
Long-term debt	573M	568.6M	564.1M	639.4M	433.8M	428.2M	425M	419.4M	415.6M	408.4M	401.4M	401.8M
Total liabilities	702.9M	704.3M	691.2M	767.5M	772.1M	775.2M	788.1M	779.5M	570.4M	571.8M	554.6M	572M
Shareholders' equity	831.6M	870.1M	892.2M	879.3M	749.6M	778.3M	798.5M	757.8M	727.2M	693.1M	653.9M	672M
Total debt	590.3M	586M	581.8M	648.6M	644.4M	638.9M	636.5M	631.4M	425.3M	418.2M	411.2M	412.1M
Net debt	491.2M	432.7M	397.7M	401.5M	398.5M	362.1M	352.8M	330.9M	277.7M	259.7M	266.9M	206.2M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	-37.9M	-42.6M	-471K	-11M	145.5M	42M	15.9M	42M	-99.6M	7M
Depreciation & amortization	12.9M	13.8M	13.2M	19.6M	19.9M	28.5M	91.5M	75.6M	78.8M	91M
Stock-based compensation	31.2M	31.6M	31.7M	33.6M	39.9M	42.2M	48.1M	47.9M	51.2M	57.5M
Change in working capital	23.2M	-13.3M	-11.9M	-31.8M	-20.1M	-25.1M	6.1M	-14.1M	-22.9M	-43.9M
Operating cash flow	34M	1.2M	46.9M	40.3M	74.8M	119.2M	131.7M	169.4M	29.3M	152M
Capital expenditure	-24.7M	-19.3M	-14.5M	-10.2M	-37.8M	-45.9M	-30.1M	-15.2M	-10.6M	—
Investing cash flow	-61.8M	-223.8M	20.6M	-128.5M	-277.6M	-20.8M	-225.2M	77.5M	-83.3M	114.8M
Dividends paid	—	—	—	—	—	—	—	—	—	—
Share repurchases	—	—	—	—	—	—	—	—	-25M	-148.3M
Financing cash flow	-8K	215.5M	0	-7.2M	174.5M	717.8M	-428.9M	-187.8M	15.1M	-372.9M
Net change in cash	-27.8M	-7M	67.4M	-95.4M	-28.2M	816.2M	-522.4M	59.2M	-38.9M	-106.1M
Free cash flow	8.7M	-1.5M	34.4M	60.4M	39.2M	79.9M	115.2M	139.5M	178.8M	136.7M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Net income	10.9M	24.9M	9M	18.9M	-143.5M	16M	4.8M	-4.8M	5.4M	1.6M	2.9M	4.7M
Depreciation & amortization	18.4M	18.5M	18.4M	18.9M	20.3M	21.2M	21.2M	27.3M	21.2M	21.3M	21.3M	21.3M
Stock-based compensation	12.5M	12.4M	13.2M	12.5M	13.2M	12.3M	14.6M	15.5M	14M	13.5M	13.5M	15M
Change in working capital	-10.2M	-17.1M	3.7M	-69K	-4.1M	-22.5M	3.6M	-7.3M	-28.2M	-6.9M	3.3M	-292K
Operating cash flow	42.4M	46.1M	44.7M	65.1M	-115.5M	35M	37.9M	12M	60.8M	43.7M	25.7M	57.5M
Capital expenditure	-3.4M	-1.8M	-2.8M	-1.6M	-4.1M	-2.1M	-8.5M	—	—	—	—	—
Investing cash flow	-4.3M	8.4M	-15.5M	-15.2M	-52.2M	-368K	-25.6M	64.9M	47.5M	19.6M	22.2M	13.1M
Dividends paid	—	—	—	—	—	—	—	—	—	—	—	—
Share repurchases	0	—	—	—	0	0	—	-50M	-50M	-48.2M	-50M	0
Financing cash flow	-27.8M	-2.9M	-2.8M	48.6M	23.9M	-29.6M	-3M	-59.1M	-257.5M	-53.4M	-59.4M	-8.5M
Net change in cash	10.3M	51.6M	26.4M	98.5M	-143.8M	5M	9.2M	17.8M	-149.2M	9.9M	-11.6M	62.1M
Free cash flow	41M	45.8M	46.3M	51.6M	49.8M	31M	26.9M	9.3M	57M	43.5M	23M	56.1M

Pacira BioSciences, Inc. Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement